See more : Bharat Wire Ropes Limited (BHARATWIRE.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Merit Medical Systems, Inc. (MMSI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Merit Medical Systems, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Kering SA (PPX.DE) Income Statement Analysis – Financial Results
- Sanoma Oyj (SANOMA.HE) Income Statement Analysis – Financial Results
- Senkon Logistics Co., Ltd. (9051.T) Income Statement Analysis – Financial Results
- Ind-Swift Limited (INDSWFTLTD.NS) Income Statement Analysis – Financial Results
- Hithink RoyalFlush Information Network Co., Ltd. (300033.SZ) Income Statement Analysis – Financial Results
Merit Medical Systems, Inc. (MMSI)
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.26B | 1.15B | 1.07B | 963.88M | 994.85M | 882.75M | 727.85M | 603.84M | 542.15M | 509.69M | 449.05M | 394.29M | 359.45M | 296.76M | 257.46M | 227.14M | 207.77M | 190.67M | 166.59M | 151.40M | 135.95M | 116.23M | 104.04M | 91.45M | 78.00M | 68.40M | 60.60M | 50.50M | 42.60M | 33.30M | 25.40M | 18.40M | 10.50M | 4.40M | 1.40M |
| Cost of Revenue | 673.49M | 631.88M | 589.42M | 562.70M | 562.49M | 487.98M | 401.60M | 338.81M | 306.37M | 284.47M | 254.68M | 212.30M | 193.98M | 168.26M | 148.66M | 133.87M | 127.98M | 117.60M | 97.49M | 83.91M | 75.23M | 67.71M | 65.94M | 56.50M | 44.30M | 39.60M | 35.10M | 26.90M | 23.30M | 17.40M | 12.30M | 7.60M | 3.80M | 2.00M | 1.70M |
| Gross Profit | 583.87M | 519.10M | 485.33M | 401.18M | 432.37M | 394.77M | 326.25M | 265.03M | 235.78M | 225.22M | 194.37M | 181.99M | 165.47M | 128.50M | 108.80M | 93.27M | 79.79M | 73.08M | 69.09M | 67.49M | 60.72M | 48.52M | 38.10M | 34.94M | 33.70M | 28.80M | 25.50M | 23.60M | 19.30M | 15.90M | 13.10M | 10.80M | 6.70M | 2.40M | -300.00K |
| Gross Profit Ratio | 46.44% | 45.10% | 45.16% | 41.62% | 43.46% | 44.72% | 44.82% | 43.89% | 43.49% | 44.19% | 43.28% | 46.16% | 46.03% | 43.30% | 42.26% | 41.06% | 38.40% | 38.33% | 41.48% | 44.58% | 44.67% | 41.74% | 36.62% | 38.21% | 43.21% | 42.11% | 42.08% | 46.73% | 45.31% | 47.75% | 51.57% | 58.70% | 63.81% | 54.55% | -21.43% |
| Research & Development | 82.73M | 75.51M | 71.25M | 57.54M | 65.62M | 59.53M | 51.40M | 45.23M | 40.81M | 36.63M | 33.89M | 27.80M | 21.94M | 15.34M | 11.17M | 9.16M | 8.69M | 8.58M | 6.99M | 5.08M | 4.63M | 4.01M | 4.12M | 3.86M | 3.60M | 3.20M | 4.40M | 2.50M | 2.30M | 2.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 373.68M | 342.53M | 335.69M | 297.72M | 327.27M | 276.02M | 229.13M | 184.40M | 156.35M | 147.89M | 128.64M | 122.11M | 104.50M | 87.62M | 64.79M | 53.13M | 48.13M | 45.49M | 38.58M | 35.07M | 30.47M | 27.73M | 24.04M | 23.30M | 20.40M | 17.50M | 15.70M | 14.30M | 12.80M | 10.20M | 9.10M | 8.00M | 4.70M | 2.10M | 0.00 |
| Other Expenses | 3.52M | 966.00K | -2.51M | -2.28M | -537.00K | 63.00K | -872.00K | -773.00K | -386.00K | 18.00K | -216.00K | -1.65M | 5.84M | 8.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.32M | 3.60M | 2.80M | 2.70M | 2.40M | 1.70M | 1.60M | 1.40M | 1.10M | 500.00K | 200.00K | 100.00K |
| Operating Expenses | 459.93M | 418.04M | 406.94M | 355.26M | 392.89M | 335.55M | 280.54M | 229.63M | 197.16M | 184.53M | 162.53M | 149.90M | 126.44M | 102.95M | 75.96M | 62.29M | 56.82M | 54.07M | 45.57M | 40.15M | 35.09M | 31.74M | 28.16M | 31.48M | 27.60M | 23.50M | 22.80M | 19.20M | 16.80M | 13.90M | 10.50M | 9.10M | 5.20M | 2.30M | 100.00K |
| Cost & Expenses | 1.13B | 1.05B | 996.36M | 917.96M | 955.38M | 823.53M | 682.14M | 568.44M | 503.53M | 468.99M | 417.21M | 362.20M | 320.42M | 271.21M | 224.62M | 196.16M | 184.80M | 171.66M | 143.06M | 124.06M | 110.32M | 99.45M | 94.10M | 87.99M | 71.90M | 63.10M | 57.90M | 46.10M | 40.10M | 31.30M | 22.80M | 16.70M | 9.00M | 4.30M | 1.80M |
| Interest Income | 2.46M | 439.00K | 769.00K | 604.00K | 0.00 | 1.20M | 381.00K | 81.00K | 272.00K | 217.00K | 255.00K | 226.00K | 129.00K | 34.00K | 178.00K | 781.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 15.51M | 6.34M | 5.26M | 9.99M | 12.41M | 10.36M | 7.74M | 8.80M | 6.23M | 8.83M | 8.04M | 604.00K | 789.00K | 596.00K | 28.00K | 17.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 101.29M | 92.20M | 95.78M | 106.82M | 104.36M | 69.55M | 53.58M | 43.76M | 37.43M | 35.93M | 32.54M | 22.53M | 19.19M | 14.86M | 12.27M | 10.24M | 9.31M | 8.10M | 5.64M | 4.49M | 4.23M | 4.38M | 4.56M | 4.32M | 3.60M | 2.80M | 2.70M | 2.40M | 1.70M | 1.60M | 1.40M | 1.10M | 500.00K | 200.00K | 100.00K |
| EBITDA | 231.44M | 181.15M | 153.45M | 102.71M | 121.00M | 129.43M | 97.29M | 78.66M | 74.85M | 76.33M | 60.43M | 50.76M | 52.93M | 32.24M | 45.39M | 42.10M | 32.41M | 19.01M | 23.52M | 27.34M | 30.37M | 21.16M | 14.50M | 7.78M | 9.70M | 8.10M | 5.40M | 6.80M | 4.20M | 3.60M | 4.00M | 2.80M | 2.00M | 300.00K | -300.00K |
| EBITDA Ratio | 18.41% | 16.91% | 16.04% | 4.59% | 3.88% | 6.85% | 6.21% | 5.75% | 7.10% | 8.03% | 7.10% | 7.78% | 10.89% | 8.62% | 12.83% | 18.11% | 15.52% | 14.25% | 17.56% | 20.95% | 21.21% | 18.22% | 13.19% | 8.95% | 12.44% | 11.99% | 8.91% | 13.47% | 9.86% | 10.51% | 15.35% | 15.22% | 18.10% | 4.55% | -21.43% |
| Operating Income | 123.94M | 87.56M | 60.92M | -62.58M | -65.71M | 58.62M | 33.07M | 34.88M | 37.54M | 40.17M | 27.84M | 29.64M | 33.19M | 17.20M | 32.85M | 30.98M | 22.97M | 19.01M | 23.52M | 27.34M | 25.63M | 16.78M | 9.94M | 3.46M | 6.10M | 5.30M | 2.70M | 4.40M | 2.50M | 2.00M | 2.60M | 1.70M | 1.50M | 100.00K | -400.00K |
| Operating Income Ratio | 9.86% | 7.61% | 5.67% | -6.49% | -6.60% | 6.64% | 4.54% | 5.78% | 6.92% | 7.88% | 6.20% | 7.52% | 9.23% | 5.80% | 12.76% | 13.64% | 11.06% | 9.97% | 14.12% | 18.06% | 18.85% | 14.43% | 9.55% | 3.78% | 7.82% | 7.75% | 4.46% | 8.71% | 5.87% | 6.01% | 10.24% | 9.24% | 14.29% | 2.27% | -28.57% |
| Total Other Income/Expenses | -11.86M | -19.44M | -7.00M | -11.67M | -13.24M | -9.10M | 2.81M | -9.49M | -6.34M | -8.59M | -8.01M | -2.02M | -315.00K | -416.00K | 247.00K | 861.00K | 429.00K | 174.00K | 379.00K | 666.00K | 885.00K | -13.00K | -151.23K | -2.69M | -1.40M | -1.10M | -1.00M | -900.00K | -600.00K | 100.00K | 0.00 | 0.00 | 200.00K | 0.00 | 400.00K |
| Income Before Tax | 112.09M | 82.63M | 53.92M | -13.23M | 2.19M | 49.52M | 35.88M | 25.39M | 31.20M | 31.57M | 19.84M | 27.62M | 32.88M | 16.79M | 33.09M | 31.85M | 23.40M | 19.18M | 23.90M | 28.01M | 27.02M | 16.76M | 9.79M | 773.85K | 4.70M | 4.20M | 1.70M | 3.50M | 1.90M | 2.10M | 2.60M | 1.70M | 1.70M | 100.00K | -400.00K |
| Income Before Tax Ratio | 8.91% | 7.18% | 5.02% | -1.37% | 0.22% | 5.61% | 4.93% | 4.20% | 5.75% | 6.19% | 4.42% | 7.00% | 9.15% | 5.66% | 12.85% | 14.02% | 11.26% | 10.06% | 14.35% | 18.50% | 19.88% | 14.42% | 9.41% | 0.85% | 6.03% | 6.14% | 2.81% | 6.93% | 4.46% | 6.31% | 10.24% | 9.24% | 16.19% | 2.27% | -28.57% |
| Income Tax Expense | 17.68M | 8.11M | 5.46M | -3.39M | -3.26M | 7.50M | 8.36M | 5.27M | 7.40M | 8.60M | 3.27M | 7.91M | 9.83M | 4.33M | 10.56M | 11.12M | 7.81M | 6.88M | 8.12M | 10.07M | 9.73M | 5.45M | 3.05M | -52.71K | 1.50M | 1.70M | 900.00K | 1.30M | 700.00K | 800.00K | 800.00K | 500.00K | 400.00K | -100.00K | 400.00K |
| Net Income | 94.41M | 74.52M | 48.45M | -9.84M | 5.45M | 42.02M | 27.52M | 20.12M | 23.80M | 22.97M | 16.57M | 19.71M | 23.04M | 12.46M | 22.53M | 20.73M | 15.59M | 12.30M | 15.78M | 17.93M | 17.30M | 11.31M | 6.74M | 826.56K | 3.20M | 2.50M | 800.00K | 2.20M | 1.20M | 1.30M | 1.80M | 1.20M | 1.30M | 100.00K | -400.00K |
| Net Income Ratio | 7.51% | 6.47% | 4.51% | -1.02% | 0.55% | 4.76% | 3.78% | 3.33% | 4.39% | 4.51% | 3.69% | 5.00% | 6.41% | 4.20% | 8.75% | 9.13% | 7.50% | 6.45% | 9.47% | 11.84% | 12.72% | 9.73% | 6.47% | 0.90% | 4.10% | 3.65% | 1.32% | 4.36% | 2.82% | 3.90% | 7.09% | 6.52% | 12.38% | 2.27% | -28.57% |
| EPS | 1.64 | 1.31 | 0.86 | -0.18 | 0.10 | 0.80 | 0.56 | 0.45 | 0.54 | 0.53 | 0.39 | 0.47 | 0.59 | 0.35 | 0.64 | 0.60 | 0.46 | 0.36 | 0.47 | 0.54 | 0.53 | 0.37 | 0.24 | 0.03 | 0.12 | 0.10 | 0.03 | 0.09 | 0.05 | 0.05 | 0.08 | 0.05 | 0.06 | 0.01 | -0.03 |
| EPS Diluted | 1.62 | 1.29 | 0.84 | -0.18 | 0.10 | 0.78 | 0.55 | 0.45 | 0.53 | 0.53 | 0.39 | 0.46 | 0.58 | 0.34 | 0.63 | 0.58 | 0.44 | 0.35 | 0.46 | 0.52 | 0.51 | 0.34 | 0.23 | 0.03 | 0.12 | 0.10 | 0.03 | 0.09 | 0.05 | 0.05 | 0.08 | 0.05 | 0.06 | 0.01 | -0.03 |
| Weighted Avg Shares Out | 57.59M | 56.81M | 56.15M | 55.43M | 55.08M | 52.27M | 48.81M | 44.41M | 44.04M | 43.14M | 42.61M | 42.18M | 39.09M | 35.29M | 35.01M | 34.71M | 34.28M | 34.17M | 33.56M | 32.88M | 31.56M | 30.11M | 28.17M | 26.84M | 26.18M | 25.76M | 25.25M | 24.48M | 23.15M | 23.76M | 22.32M | 21.93M | 20.52M | 11.57M | 13.89M |
| Weighted Avg Shares Out (Dil) | 58.36M | 57.67M | 57.36M | 55.43M | 56.24M | 53.93M | 50.10M | 44.86M | 44.51M | 43.41M | 42.88M | 42.61M | 39.73M | 35.98M | 35.76M | 35.69M | 35.26M | 35.31M | 34.81M | 34.61M | 33.79M | 32.80M | 29.84M | 27.29M | 26.27M | 26.00M | 25.25M | 24.59M | 23.15M | 23.76M | 22.32M | 21.93M | 20.52M | 11.57M | 13.89M |
Merit Medical: Undervalued With Multiple Growth Drivers In Play
Merit Medical has shown solid performance with revenue and EBITDA growth, but has only tracked the broader med-tech market higher as investors wait for more exciting drivers. The company's WRAPSODY endovascular stent graft has potential to exceed management's projections, and...
Merit Medical recalling plastic syringes supplied by Jiangsu Shenli Medical, US FDA says
The U.S. Food and Drug Administration said on Friday that Merit Medical Systems has initiated a recall for plastic syringes supplied by Jiangsu Shenli Medical Production.
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical (MMSI) Up 5% Since Last Earnings Report: Can It Continue?
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock?
Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
Merit Medical's (MMSI) latest offering is likely to create an efficient approach to inflation, thereby providing improved patient care.
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
Merit Medical Launches basixSKY™ Inflation Device
Versatile analog device offers fast inflation and ease of use, streamlining patient care Versatile analog device offers fast inflation and ease of use, streamlining patient care
Merit Medical Shareholders Elect Silvia M. Perez as New Director
Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit's Board of Directors Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit's Board of Directors
Source: https://incomestatements.info
Category: Stock Reports